Introduction: Canine otitis externa (OE) is a frequently-diagnosed condition in veterinary practices worldwide. is commonly associated with chronic and recalcitrant canine OE, but studies with detailed genomic and phenotypic characterisation of clinical isolates are lacking.
Methods: canine OE isolates ( = 253) were collected from different geographical locations in Europe and characterised with respect to antimicrobial resistance and biofilm formation. A subset ( = 35) were genome sequenced then characterised with respect to diversity, and complement of virulence, antimicrobial resistance, and biofilm-associated genes.
Results: Genome-sequenced strains were distributed among phylogroups, showing no obvious clonality. However, two isolates belonged to ST111 and ST244 respectively,-MLST sequence types associated with AMR nosocomial infections in humans. Resistance to fluoroquinolones was detected in 25% of isolates, and multidrug resistance detected in 1.6%, though this did not always correlate with the presence of antimicrobial resistance genes. Additionally, 82% of isolates were characterised as forming strong biofilms.
Discussion: For the first time, this study has characterised a large multinational collection of isolates from canine otitis with a combination of whole genome sequencing, phenotypic screening and bioinformatic analysis. These strains did not cluster together based on genomic diversity or virulence gene complement, supporting their likely environmental origin. However, the identification of ST111 and ST244, important 'high-risk' sequence types, could suggest potential spread between humans and dogs. Furthermore, we found that most strains were formed strong biofilms, and exhibited a significant level of resistance towards critically important antimicrobials. These findings could assist in the selection of appropriate treatments for canine OE as well as possibly identifying one health risks of these infections for cohabiting pets and humans.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891389 | PMC |
http://dx.doi.org/10.3389/fmicb.2025.1526843 | DOI Listing |
Front Microbiol
February 2025
School of Veterinary Medicine and Science, University of Nottingham, Nottingham, United Kingdom.
Introduction: Canine otitis externa (OE) is a frequently-diagnosed condition in veterinary practices worldwide. is commonly associated with chronic and recalcitrant canine OE, but studies with detailed genomic and phenotypic characterisation of clinical isolates are lacking.
Methods: canine OE isolates ( = 253) were collected from different geographical locations in Europe and characterised with respect to antimicrobial resistance and biofilm formation.
BMC Vet Res
March 2025
Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of London, Blizard Building, 4 Newark Street, London, E1 2AT, UK.
Background: Staphylococcus spp., and Pseudomonas spp., including multidrug resistant staphylococci are frequent isolates from canine otitis externa and atopic dermatitis.
View Article and Find Full Text PDFVet Dermatol
March 2025
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin in Madison, Madison, Wisconsin, USA.
Background: Early and accurate diagnosis of otitis externa is crucial for correct management yet can often be challenging. Artificial intelligence (AI) is a valuable diagnostic tool in human medicine. Currently, no such tool is available in veterinary dermatology/otology.
View Article and Find Full Text PDFVet Dermatol
April 2025
Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide, Roseworthy, South Australia, Australia.
Background: Biofilm production by canine otitis externa (COE) pathogens and resistance development to multiple antimicrobials are commonly reported problems in veterinary practice. The use of adjuvants to disrupt biofilms may be a viable adjunctive therapy.
Hypothesis/objectives: To compare the in vitro antibiofilm activity against COE pathogens of three otic cleansers: PHMB-EDTA (poly [hexamethylene] biguanide hydrochloride and disodium edetate), N-acetylcysteine (NAC) and Triz-EDTA.
Vet Med Sci
March 2025
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea.
Background: Allergen-specific immunotherapy (ASIT) is a highly effective treatment for atopic dermatitis. In humans, it has been reported to be significantly more effective than medication alone for the treatment of otitis media. ASIT can also be used in dogs, but it is not typically the first-line treatment for otitis externa and media.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!